Clinical Trials
48 trialsGRECCAR 5
University Hospital, Bordeaux
ALTAIR
National Cancer Center Hospital East
ALLAN
Lund University Hospital
Post-Marketing Surveillance Study of OTEZLA
Amgen
ARROW
Hoffmann-La Roche
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Point of Care 3D Ultrasound for Various Applications: A Pilot Study
Duke University
Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects
Mayo Clinic
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction
Catalysis SL
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
Catalysis SL
CanStem303C
Sumitomo Pharma America, Inc.
Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )
Innovent Biologics (Suzhou) Co. Ltd.
ALTER-C-002
Zhejiang University
CPET and Outcome After Oesophagogastric Cancer Surgery
University Hospital Southampton NHS Foundation Trust
SOLAR
Taiho Pharmaceutical Co., Ltd.
Evaluation of the Bowel Cleansing in Hospitalized Patients Using Pure-Vu System
Motus GI Medical Technologies Ltd
SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
TINGLE
Cedars-Sinai Medical Center
Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
CLEAR-C
Zhejiang University
PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer
Isofol Medical AB
An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer
Isofol Medical AB
Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer
Isofol Medical AB
DUORESECT
Universidad de Extremadura
Colorectal Cancer Screening in a Community Health Setting
University of Pennsylvania
Erings™
Portsmouth Hospitals NHS Trust
OxyTarget
University Hospital, Akershus
Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)
Novartis
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Yale University
Microbiome Test for the Detection of Colorectal Polyps and Cancer
Metabiomics Corp
OCEANIA
Exact Sciences Corporation
Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients
M.D. Anderson Cancer Center
FDG-PET-CT and Biomarkers in Esophageal Cancer
M.D. Anderson Cancer Center
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
Exact Sciences Corporation
DeeP-C
Exact Sciences Corporation
Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Swedish Medical Center
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Exact Sciences Corporation
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
Exact Sciences Corporation
Evolution® Biliary Stent System Clinical Study
Cook Group Incorporated
Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease
FDA Office of Orphan Products Development
PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide
M.D. Anderson Cancer Center
SMC
Karolinska Institutet
COSM
Karolinska Institutet
PreDuoFAP
Radboud University Medical Center
Huachansu & Gemcitabine in Pancreatic Cancer
M.D. Anderson Cancer Center
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy
M.D. Anderson Cancer Center
The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients
Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd
Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
Bellus Health Inc. - a GSK company